2. Mandal A., Viswanathan C. Natural killer cells: In health and disease. Hematol. Oncol. Stem. Cell Ther. 2015; 8(2): 47–55

3. George L.C., Rowe M., Fox C.P. Epstein-barr virus and the pathogenesis of T and NK lymphoma: A mystery unsolved. Curr. Hematol. Malig. Rep. 2012; (7): 276–84. doi: 10.1007/s11899-012-0136-z.

4. van Erp E.A., van Kampen M.R. , van Kasteren P.B. , de Witе J. Viral Infection of Human Natural Killer Cells. Viruses 2019; 11(3): 243. doi: 10.3390/v11030243

5. Schuster I.S., Coudert J.D., Andoniou C.E., Degli-Esposti M.A. «Natural Regulators»: NK Cells as Modulators of T Cell Immunity. Front. Immunol. 2016; (7): 235. doi: 10.3389/fimmu.2016.00235

6. Stabile H., Fionda C., Gismondi A., Santoni A. Role of distinct natural killer cell subsets in anticancer response. Front Immunol. 2017; (8): 293. DOI: 10.3389/fimmu.2017.00293

7. Zhang Y., Huang B. The development and diversity of ILCs, NK cells and their relevance in health and diseases. Adv. Exp. Med. Biol. 2017; 1024: 225–44. doi: 10.1007/978-981-10-5987-2_11

8. Abel A.M., Chao Yang M., Thakar S., Malarkannan S. Natural Killer Cells Development, Maturation, and Clinical Utilization. Front Immunol. 2018; (9): 1869. doi: 10.3389/fimmu.2018.01869

9. Björkström N.K., Riese P., Heuts F. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010; 116(19): 3853–64. doi: 10.3389/fimmu.2017.00293

10. Handgretinger R., Lang P., André M.C. Exploitation of natural killer cells for the treatment of acute leukemia. Blood 2016; 127(26): 3341–9. doi: 10.1182/blood-2015-12-629055.

11. Kuczer M., Czarniewska А., Majewska A., Różanowska M., Rosiński G., Lisowski M. Novel analogs of alloferon: Synthesis, conformational studies, pro-apoptotic and antiviral activity. Bioorg. Chem. 2016; 66: 12–20. doi: 10.1016/j.bioorg.2016.03.002

12. Angus K.L., Griffiths G.M. Cell polarisation and the immunological synapse. Curr. Opin. Cell Biol. 2013; 25(1): 85–91. doi: 10.1016/j.ceb.2012.08.013

13. Dongfang L., Jose A M., Xufeng S.W., Hammer J.A. 3rd, Long E.O. Two modes of lytic granule fusion during degranulation by natural killer cells. Immunol. Cell. Biol. 2011; 89(6): 728–38. doi: 10.1038/icb.2010.167

14. Kiesgen S., Messinger J.C., Chintala N.K., Tano Z, Adusumilli P.S. Comparative analysis of assays to measure CAR T-cell-mediated cytotoxicity. Nat. Protoc. 2021; 16(3): 1331–42. doi: 10.1038/s41596-020-00467-0

15. Lee N., Bae S., Kim H. et al. Inhibition of lytic reactivation of Kaposi’s sarcoma-associated herpesvirus by alloferon. Antivir. Ther. 2011; 16(1): 17–26. doi: 10.3851/IMP1709

16. Thomas D., Michou V., TegosV., Patargias T., Moustakarias T., Kanakas N. et al. The effect of valacyclovir treatment on natural killer cells of infertile women. Am. J. Reprod. Immunol. 2004; 51(3): 248–55.DOI: 10.1111/j.1600-0897.2004.00152.x

17. Kuczer M., Majewska A., Zahorska R. New alloferon analogues: synthesis and antiviral properties. Chem. Biol. Drug Des. 2013; 81(2): 302–9. doi: 10.1111/cbdd.12020

18. Chernysh S., Kim S.I., Bekker G., Pleskach V.A., Filatova N.A., Anikin V.B. et al. Antiviral and antitumor peptides from insects. Proc. Nat. Acad. Sci. USA. 2002; 99(20): 12628–32. doi: [10.1073/pnas.192301899]

19. Черныш С.И. Аллокины (цитокиноподобные пептиды насекомых) как модуляторы иммунного ответа человека и других млекопитающих. Российский иммунологический журнал 2004; 9(1): 36.

Chernysh S.I. [Alloquins (cytokine-like peptides of insects) as modulators of the immune response of humans and other mammals]. Russian Journal of Immunology 2004; 9(1): 36. (In Russ.).